RNA pseudoknots that inhibit human immunodeficiency virus type 1 reverse transcriptase.
AUTOR(ES)
Tuerk, C
RESUMO
High-affinity ligands of the reverse transcriptase of human immunodeficiency virus type 1 (HIV-1) were isolated by the SELEX procedure (systematic evolution of ligands by exponential enrichment) from RNA populations randomized at 32 positions. Analysis of these ligands revealed a pseudoknot consensus with primary sequence bias at some positions. We demonstrated that at least one of the ligands inhibits cDNA synthesis by HIV reverse transcriptase but fails to inhibit other reverse transcriptases. These experiments highlight the power of SELEX to yield highly specific ligands that reduce the activity of target proteins. Such ligands may provide therapeutic reagents for viral and other diseases.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=49630Documentos Relacionados
- Substrate inhibition of the human immunodeficiency virus type 1 reverse transcriptase.
- Double-stranded RNA-dependent RNase activity associated with human immunodeficiency virus type 1 reverse transcriptase.
- Two highly antigenic sites in the human immunodeficiency virus type 1 reverse transcriptase.
- Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.
- Action of uracil analogs on human immunodeficiency virus type 1 and its reverse transcriptase.
